ANXA2, a member of the calcium-dependent membrane-bound protein family, has been implicated in the development of oncogenesis and various inflammatory diseases, such as hepatocellular carcinoma (HCC), systemic lupus erythematosus (SLE), and inflammatory bowel disease (IBD) [61–63]. This evidence concerns the gene ANXA2 and inflammatory bowel disease.